In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- Runhappy Faces Five in Ack Ack
- Snowden Death Investigation 'Inactive'
- Air Force Blue Retired to Ashford Stud
- Mirahmadi New Full-Time Caller at Golden Gate
- Flintshire Rolls Into Joe Hirsch Turf Classic
- Racing's Stars Set for Santa Anita Saturday
- Tapit, War Front Dominate Keeneland Sale
- Pinhooking Rookie Scores Big at Keeneland
- Texas Chrome Pointing to Dirt Mile
- California Chrome Arrives at Santa Anita